Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer
Key facts
- Who runs it
- National Cancer Institute (NCI)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 7 Apr 2026
- Expected to end
- 1 Apr 2029
- Type of study
- Observational
- Treatments tested
- Quality Assessment
- Record updated
- 3 April 2026
- Why it stopped
- This record was submitted inadvertently and was not intended for registration, as NIH is not the responsible party and the study is not an applicable clinical trial. As PRS does not permit deletion, the record has been marked as withdrawn.
Who can take part
- Age
- 12 years to 120 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Other criteria
- ELIGIBILITY CRITERIA:
- Stakeholder Panel:; Patients
- Ages 12-39y, inclusive
- English- or Spanish-speaking and reading
- Living with stage IV or recurrent cancer; Caregivers
- Must be actively involved in the care of an AYA patient
- English- or Spanish-speaking and reading; Clinicians
- Must care for AYA patients
- Can be of any discipline, including oncologists, nurses, social workers, psychologists, and chaplains; -Surveys and Interviews (Aims 1 and 2):
- Patients ages 12-39y, inclusive
- English- or Spanish-speaking and reading
- Living with stage IV or recurrent cancer; Survey Notes: 1) For AYAs <18y, family caregivers will be asked to respond to survey questions. For AYAs >=18y, family caregiver participation is optional. 2) Patients will be eligible without respect to timing of diagnosis or recurrence as long as they are living with advanced disease; Interview Notes: 1) Survey participants will be eligible at the time of completion of the final survey; AYAs who did not participate in surveys (e.g., if enrollment to the survey cohort is already complete) will also be eligible. 2) Patients will be eligible without respect to timing of diagnosis or recurrence as long as they are living with advanced disease
Where in United States
- National Institutes of Health Clinical CenterBethesda, United States
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Cancer among adolescents and young adults (AYAs) is on the rise, with nearly 90,000 AYAs diagnosed in the US each year. While most are cured, an estimated 15,000 AYAs die of cancer in the US annually creating profound suffering for those whose lives are cut short and for those who survive them. AYAs face unique challenges near the end of life (EOL). The tragic circumstances surrounding young lives cut short by cancer often provoke intensive efforts to prolong life, sometimes at the cost of comfort and quality. Patients, families, and even clinicians experience these deaths as tragic, a departure from the natural order of life in which each generation outlives the one before it.
The current study is designed to ensure future efforts to improve care is guided by patient perspectives. The aims of the study are to 1) measure the quality of care received by adolescents and young adults (AYAs) living with advanced cancer using patient-centered quality measures, focusing specifically on potential unmet psychosocial, spiritual, and communication needs and 2) to assess disparities in end-of-life (EOL) care quality and barriers to care experienced by Black, Asian, and Hispanic AYAs. Our research will enable us to answer remaining critically unanswered questions and unmet needs about EOL care quality and barriers to care experienced by AYAs.
The group in the trial
- AYA Cancer Patients, Caregivers, Clinicians
AYA participants with advanced cancer and caregivers or clinicians for AYA patients with advanced cancer.
Treatment: Quality Assessment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 3 April 2026